Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
RLI Corp
RLI
$5.89B
| $1.28M | ﹤0.01% |
19,284
+754
| +4% | +$50.1K |
|
477
Amkor Technology
AMKR
$13.7B
| $1.26M | ﹤0.01% |
48,251
+3,568
| +8% | +$97.6K |
|
478
Ethan Allen Interiors
ETD
$603M
| $1.25M | ﹤0.01% |
45,694
+10,662
| +30% | +$303K |
|
479
Mueller Industries
MLI
$15.2B
| $1.25M | ﹤0.01% |
68,036
-2,852
| -4% | -$49.8K |
|
480
RPC Inc
RES
$1.3B
| $1.2M | ﹤0.01% |
156,062
+15,122
| +11% | +$134K |
|
481
Commercial Metals
CMC
$8.31B
| $1.19M | ﹤0.01% |
24,337
+277
| +1% | +$14.3K |
|
|
BSX.PRA
482
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $1.16M | ﹤0.01% |
9,616
| – | – |
|
|
TMHC
483
DELISTED
Taylor Morrison
TMHC
| $1.12M | ﹤0.01% |
29,343
-382
| -1% | -$13.4K |
|
484
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $1.1M | ﹤0.01% |
22,509
-100,122
| -82% | -$4.82M |
|
485
Rambus
RMBS
$11B
| $1.09M | ﹤0.01% |
+21,204
| New | +$911K |
|
486
Belden
BDC
$5.19B
| $1.08M | ﹤0.01% |
12,472
-524
| -4% | -$43.5K |
|
|
ARI
487
Apollo Commercial Real Estate
ARI
$885M
| $1.08M | ﹤0.01% |
+115,793
| New | +$1.28M |
|
|
DX
488
Dynex Capital
DX
$3.21B
| $1.07M | ﹤0.01% |
+88,418
| New | +$1.18M |
|
489
CBIZ
CBZ
$2.96B
| $1.07M | ﹤0.01% |
21,647
-362
| -2% | -$17.4K |
|
490
Marten Transport
MRTN
$1.22B
| $1.06M | ﹤0.01% |
50,792
-2,122
| -4% | -$45.1K |
|
491
Option Care Health
OPCH
$3.56B
| $1.04M | ﹤0.01% |
32,710
-6,838
| -17% | -$205K |
|
492
Murphy Oil
MUR
$4.78B
| $1.04M | ﹤0.01% |
28,065
+320
| +1% | +$12.8K |
|
493
DigitalBridge
DBRG
$2.95B
| $1.03M | ﹤0.01% |
+85,942
| New | +$1.08M |
|
494
Hilton Grand Vacations
HGV
$3.55B
| $1.02M | ﹤0.01% |
23,054
-380
| -2% | -$17.2K |
|
495
Micron Technology
MU
$991B
| $1.01M | ﹤0.01% |
16,793
+10,551
| +169% | +$618K |
|
496
Golar LNG
GLNG
$5.13B
| $981K | ﹤0.01% |
45,397
-3,947
| -8% | -$88.4K |
|
497
iShares North American Natural Resources ETF
IGE
$758M
| $959K | ﹤0.01% |
24,492
+10,775
| +79% | +$435K |
|
498
Nelnet
NNI
$4.7B
| $949K | ﹤0.01% |
10,332
-432
| -4% | -$40K |
|
|
GMS
499
DELISTED
GMS Inc
GMS
| $945K | ﹤0.01% |
16,332
-41
| -0.3% | -$2.32K |
|
500
Paylocity
PCTY
$7.98B
| $941K | ﹤0.01% |
4,734
+464
| +11% | +$91.3K |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.